NCT02709265View on ClinicalTrials.gov

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Healthy

Interventions

DRUG

amikacin/fosfomycin

single aerosolized dose

Trial Locations (1)

55404

DaVita Clinical Research, Minneapolis

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Cardeas Pharma

INDUSTRY